Structured evidence table for Lutein Visual Performance Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Lutein Visual Performance Randomized Trial | However, these approaches require repeated invasive injections and are associated with considerable economic burden and procedural risks [,]. | 1 | Wang Wei-Xiang (2026) | From Supplements to Sight: Quantifying the Impact of Lutein and Carotenoid on Age‐Related Macular Degeneration—A Systematic Review and Meta‐Analysis of Randomized Controlled Trials |
| Lutein Visual Performance Randomized Trial | Experimental and clinical studies have suggested that increased macular pigment levels may support visual performance and potentially attenuate AMD progression [–]. | 1 | Wang Wei-Xiang (2026) | From Supplements to Sight: Quantifying the Impact of Lutein and Carotenoid on Age‐Related Macular Degeneration—A Systematic Review and Meta‐Analysis of Randomized Controlled Trials |
| Lutein Visual Performance Randomized Trial | Some findings from the Age‐Related Eye Disease Study 2 (AREDS2) indicated that lutein and zeaxanthin supplementation significantly reduced the risk of progression to late‐stage AMD []. | 1 | Wang Wei-Xiang (2026) | From Supplements to Sight: Quantifying the Impact of Lutein and Carotenoid on Age‐Related Macular Degeneration—A Systematic Review and Meta‐Analysis of Randomized Controlled Trials |
| Lutein Visual Performance Randomized Trial | 1 2 3 4 5 6 7 Age‐related macular degeneration (AMD) remains one of the leading causes of irreversible central vision loss among individuals over 65 years of age worldwide. | 1 | Wang Wei-Xiang (2026) | From Supplements to Sight: Quantifying the Impact of Lutein and Carotenoid on Age‐Related Macular Degeneration—A Systematic Review and Meta‐Analysis of Randomized Controlled Trials |
| Lutein Visual Performance Randomized Trial | This systematic review aimed to evaluate randomized controlled trial (RCT) evidence on the effects of carotenoids, anthocyanins, polyunsaturated fatty acids, and combined nutraceutical formulations on refractive outcomes, axial length, macular pigment optical density (MPOD), visual function, and symptoms of visual fatigue. | 1 | Martinez-Perez C (2025) | Nutritional Supplementation for Myopia Prevention and Control: A Systematic Review of Randomized Controlled Trials. |
| Lutein Visual Performance Randomized Trial | Eligible studies were RCTs involving individuals with myopia or at risk of myopia, comparing nutritional supplementation with placebo or active controls. | 1 | Martinez-Perez C (2025) | Nutritional Supplementation for Myopia Prevention and Control: A Systematic Review of Randomized Controlled Trials. |
| Lutein Visual Performance Randomized Trial | Two reviewers independently screened studies, extracted data, and assessed risk of bias using the Cochrane RoB 2 tool. | 1 | Martinez-Perez C (2025) | Nutritional Supplementation for Myopia Prevention and Control: A Systematic Review of Randomized Controlled Trials. |
| Lutein Visual Performance Randomized Trial | Background/objectives Nutritional supplementation has been proposed as a potential adjunct strategy in myopia prevention and control through antioxidative, anti-inflammatory, and extracellular matrix-regulating mechanisms. | 1 | Martinez-Perez C (2025) | Nutritional Supplementation for Myopia Prevention and Control: A Systematic Review of Randomized Controlled Trials. |
Source documents